RCE 0.00% 46.0¢ recce pharmaceuticals ltd

News: RCE Recce Pharmaceuticals Announces Positive Preclinical Efficacy Data Against Who Priority...

  1. 191,621 Posts.
    lightbulb Created with Sketch. 2809

    July 10 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :

    • RECCE PHARMACEUTICALS LTD - R327 DEMONSTRATES 99.99999% LOG REDUCTION IN A. BAUMANNII
    • RECCE PHARMACEUTICALS ANNOUNCES POSITIVE PRECLINICAL EFFICACY DATA AGAINST WHO PRIORITY PATHOGEN ACINETOBACTER BAUMANNII
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.0M
Open High Low Value Volume
46.0¢ 46.5¢ 46.0¢ $19.60K 42.56K

Buyers (Bids)

No. Vol. Price($)
3 41004 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 38272 2
View Market Depth
Last trade - 15.56pm 26/07/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.